BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Hard-to-Treat Diseases

Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platf...

April 14, 2025 | News

AGC Biologics Sets New Benchmark in Japan With 5,000 L Single-Use Bioreactors at Yokohama CDMO Site

New CDMO site introducing the most advanced and large-scale single-use bioreactors in Japan AGC announced a strategic decision about the large-scale singl...

April 08, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU Approved in EU for Earlier Treatment of HER2 Low and Ultralow Breast Cancer

Based on DESTINY-Breast06 phase 3 trial results which showed ENHERTU demonstrated superiority versus chemotherapy with a median progression-free surviv...

April 04, 2025 | News

PeptiGrowth to Launch Synthetic KGF Alternative Peptide PG-012 in April 2025 for Regenerative Medicine Applications

PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called "KG...

April 02, 2025 | News

Luye Pharma’s Twice-Weekly Rivastigmine Patch Approved in Japan for Alzheimer’s

Luye Pharma Group announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japa...

April 01, 2025 | News

Alamar Biosciences Expands APAC Presence with Five New Distribution Partnerships

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new dis...

March 20, 2025 | News

Akeso’s Penpulimab Secures NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National ...

March 18, 2025 | News

Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation

What are the most significant recent breakthroughs in cell and gene therapy and how is Thermo Fisher Scientific involved in these advancements? In 2024, t...

March 14, 2025 | Interaction

Japan Grants Orphan Drug Designation to Lundbeck’s Amlenetug for Multiple System Atrophy

The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetu...

March 11, 2025 | News

NEC Partners with Nagasaki University and CEPI to Advance AI-Driven mRNA Vaccine for SFTS and Future Epidemic Threats

NEC Partners with Nagasaki University and CEPI to Develop AI-Driven mRNA Vaccine for SFTS and Future Epidemic Threats NEC Corporation (NEC; TSE: 6701) has...

March 10, 2025 | News

Merck Life Science Expands in Japan with New Tokyo Office

Merck Life Science, a global leader in the life sciences sector, has strengthened its commitment to the Japanese market with the inauguration of a new offi...

March 06, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU Recommended for EU Approval for HER2 Low and HER2 Ultralow Metastatic Breast Cancer

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been recommended for approval in th...

March 03, 2025 | News

WuXi Biologics Passes Japan’s PMDA GMP Inspection for Wuxi Drug Substance Facilities

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has...

February 28, 2025 | News

Japan’s AMR Response 2013–2025: Key Lessons and Global Implications

The World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan’s AMR Response 2013–2025, providing a com...

February 26, 2025 | News

Stay Connected